 Connection
Lisa Maier to Polymorphism, Genetic
This is a "connection" page, showing publications Lisa Maier has written about Polymorphism, Genetic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.410 |
|
|
|
-
Pacheco KA, Rose CS, Silveira LJ, Van Dyke MV, Goelz K, MacPhail K, Maier LA. Gene-environment interactions influence airways function in laboratory animal workers. J Allergy Clin Immunol. 2010 Aug; 126(2):232-40.
Score: 0.275
-
Sato H, Silveira L, Spagnolo P, Gillespie M, Gottschall EB, Welsh KI, du Bois RM, Newman LS, Maier LA. CC chemokine receptor 5 gene polymorphisms in beryllium disease. Eur Respir J. 2010 Aug; 36(2):331-8.
Score: 0.266
-
Sato H, Silveira L, Fingerlin T, Dockstader K, Gillespie M, Lagan AL, Lympany P, Sawyer RT, du Bois RM, Welsh KI, Maier LA. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization. J Allergy Clin Immunol. 2007 Mar; 119(3):687-96.
Score: 0.217
-
Crooks J, Mroz MM, VanDyke M, McGrath A, Schuler C, McCanlies EC, Virji MA, Rosenman KD, Rossman M, Rice C, Monos D, Fingerlin TE, Maier LA. HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease. Occup Environ Med. 2022 02; 79(2):120-126.
Score: 0.150
-
Maier LA, Raynolds MV, Young DA, Barker EA, Newman LS. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am J Respir Crit Care Med. 1999 Apr; 159(4 Pt 1):1342-50.
Score: 0.126
-
Silveira LJ, McCanlies EC, Fingerlin TE, Van Dyke MV, Mroz MM, Strand M, Fontenot AP, Bowerman N, Dabelea DM, Schuler CR, Weston A, Maier LA. Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove. J Immunol. 2012 Oct 15; 189(8):4014-23.
Score: 0.080
-
Samuel G, Maier LA. Immunology of chronic beryllium disease. Curr Opin Allergy Clin Immunol. 2008 Apr; 8(2):126-34.
Score: 0.059
-
Sato H, Spagnolo P, Silveira L, Welsh KI, du Bois RM, Newman LS, Maier LA. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals. Tissue Antigens. 2007 Dec; 70(6):480-6.
Score: 0.057
-
Bekris LM, Viernes HM, Farin FM, Maier LA, Kavanagh TJ, Takaro TK. Chronic beryllium disease and glutathione biosynthesis genes. J Occup Environ Med. 2006 Jun; 48(6):599-606.
Score: 0.052
-
Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol. 2003 Dec 15; 171(12):6910-8.
Score: 0.044
-
Maier LA, Sawyer RT, Bauer RA, Kittle LA, Lympany P, McGrath D, Dubois R, Daniloff E, Rose CS, Newman LS. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease. Am J Respir Crit Care Med. 2001 Oct 01; 164(7):1192-9.
Score: 0.038
-
Liu B, Maier LA, Hamzeh N, MacPhail K, Mroz MM, Liu H, Li L. Polymorphism of FCGR3A gene in chronic beryllium disease. Genes Immun. 2019 07; 20(6):493-499.
Score: 0.030
-
Sato H, Woodhead FA, Ahmad T, Grutters JC, Spagnolo P, van den Bosch JM, Maier LA, Newman LS, Nagai S, Izumi T, Wells AU, du Bois RM, Welsh KI. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet. 2010 Oct 15; 19(20):4100-11.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|